A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances

PURPOSE: Dim light vision disturbances (DLD) comprise a wide range of symptoms affecting the quality of vision at low illumination including glare, halos, and starbursts. This exploratory study investigated 1.0% phentolamine mesylate ophthalmic solution (PMOS) as a treatment to improve vision and im...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepose, Jay, Brigell, Mitchell, Lazar, Eliot, Heisel, Curtis, Yousif, Jonah, Rahmani, Kavon, Kolli, Ajay, Hwang, Min, Mitrano, Cara, Lazar, Audrey, Charizanis, Konstantinos, Sooch, Mina, McDonald, Marguerite
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548101/
https://www.ncbi.nlm.nih.gov/pubmed/36209072
http://dx.doi.org/10.1186/s12886-022-02621-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548101/
https://www.ncbi.nlm.nih.gov/pubmed/36209072
http://dx.doi.org/10.1186/s12886-022-02621-6

Ejemplares similares